Aviva’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$482K Sell
6,563
-3,805
-37% -$279K ﹤0.01% 764
2025
Q1
$1.18M Sell
10,368
-588
-5% -$67.2K ﹤0.01% 613
2024
Q4
$552K Sell
10,956
-6,371
-37% -$321K ﹤0.01% 785
2024
Q3
$802K Sell
17,327
-3,893
-18% -$180K ﹤0.01% 626
2024
Q2
$689K Sell
21,220
-5,265
-20% -$171K ﹤0.01% 680
2024
Q1
$667K Buy
26,485
+4,072
+18% +$103K ﹤0.01% 749
2023
Q4
$728K Buy
+22,413
New +$728K ﹤0.01% 724
2022
Q1
Sell
-127,855
Closed -$2.53M 1069
2021
Q4
$2.53M Buy
127,855
+48,808
+62% +$967K 0.01% 791
2021
Q3
$1.56M Buy
+79,047
New +$1.56M 0.01% 876
2021
Q1
Sell
-70,676
Closed -$1.85M 950
2020
Q4
$1.85M Sell
70,676
-57,297
-45% -$1.5M 0.01% 691
2020
Q3
$2.23M Sell
127,973
-8,376
-6% -$146K 0.01% 737
2020
Q2
$2.29M Sell
136,349
-180,494
-57% -$3.04M 0.01% 699
2020
Q1
$3.77M Buy
+316,843
New +$3.77M 0.03% 506